Bloomberg: IPOX® Founder Josef Schuster on the US IPO Market's Rebound and What Lies Ahead
In a recent Bloomberg article, IPOX® Founder Josef Schuster provided his expert commentary on the U.S. IPO market's recent surge in performance. He described a "positive feedback loop" where unsatisfied demand for one hot listing is driving investor orders for the next, contributing to the market's momentum. Schuster noted that while this enthusiasm is promising, the true test for the recovery will be the fundamental strength shown in the first quarterly earnings from these newly public companies, stating, "When you see the first set of earnings from some of these companies, you will really see how substantial this recovery of the IPO market is going to be."
Reuters: IPOX® Vice President Kat Liu Comments on Insurtech Slide's IPO Plans
In a recent Reuters article, IPOX® VP Kat Liu, provided commentary on the upcoming IPO of property insurance technology company Slide. The company is reportedly targeting a valuation of up to $2.12 billion and aims to raise as much as $340 million.
Reuters: IPOX® Associate Dr. Lukas Muehlbauer on Caris Life Sciences' IPO Valuation
In a recent report by Reuters, IPOX® Research Associate Dr. Lukas Muehlbauer provided commentary on the upcoming U.S. initial public offering of cancer diagnostic firm Caris Life Sciences. The company is aiming for a valuation of up to $5.3 billion, seeking to raise as much as $423.5 million.
The IPOX® Update 6/6/2025
Global IPO markets are active, with strong showings in the Middle East as Saudi airline flynas and healthcare firm SMC launch successful offerings. The Asia-Pacific region is also bustling with major listings in the Philippines and Australia, while Hong Kong's market rebounds. In contrast, London faces setbacks as fintech Wise shifts its primary listing to the U.S. and Cobalt Holdings cancels its float, even as U.S. crypto and aerospace firms successfully go public.
Reuters: IPOX® Analyst Lukas Muehlbauer Comments on IPO Market Momentum
In a Reuters report on Circle's successful market debut, IPOX® Research Associate Lukas Muehlbauer offered context on the strengthening IPO pipeline. He observed that the most successful recent listings have been from firms in resilient industries, stating they were "largely by companies less exposed to international supply chain risks" and that the trend would likely continue for sectors such as AI, defense, or fintech.
Reuters: IPOX® Vice President Kat Liu Comments on Gemini's IPO Filing and Crypto Market Momentum
In a Reuters feature on Gemini's recent IPO filing, IPOX® Vice President Kat Liu commented on the growing trend of digital asset firms going public. Liu explained that this move signals a readiness from long-anticipated firms to re-engage with public capital. She noted, "investor appetite is returning, especially for companies with well-defined business models in strategic sectors such as fintech, AI and digital assets," highlighting the renewed market vigor for such offerings.
The IPOX® Update 5/30/2025
Global IPO activity remains dynamic. The U.S. sees Netskope targeting a $5B+ IPO valuation and Omada Health raising $158M. Europe anticipates a potential £4.5B Automobile Association deal and Cobalt Holdings' $230M IPO. In Asia-Pacific, Shein considers a Hong Kong listing, Sony plans a major financial arm spin-off, and 'Baby Shark' creator Pinkfong files its IPO, showcasing diverse market movements across key financial hubs.
The IPOX® Update 5/23/2025
Global IPO markets exhibit robust activity across regions. MENA sees significant listings like Flynas raising $1.1B and Dubai Residential REIT's $584M debut. In the U.S., Circle targets a $5B+ IPO valuation, alongside Medtronic's diabetes unit spin-off and Voyager's NYSE filing. Asia-Pacific highlights Maynilad's $820M IPO and new Chinese regulations for overseas listings, while Europe shows activity with Cobalt Holdings and a potential Sentia IPO, signaling broad market momentum.
Bloomberg: IPOX® Founder Josef Schuster Comments on Resilient US IPO Market Amid Volatility
In a recent Bloomberg article, IPOX® Founder Josef Schuster provided his expert commentary on the U.S. IPO market's striking resilience despite recent volatility. He noted the market's ability to withstand bond market pressures, highlighting that strong performers like CoreWeave are boosting investor confidence. Schuster observed that "risk appetite is rising for certain deals," indicating potential for continued positive momentum given solid company fundamentals and performance.
Bloomberg: IPOX® CEO Schuster Comments on Dubai's Property Boom and REIT IPO Potential
In a recent Bloomberg article, IPOX® Founder Josef Schuster provided his expert commentary on Dubai's surging property market and its influence on REIT IPOs. He highlighted the expectation for REITs to "gain traction in the UAE as a separate tradeable asset class," given the strong investor interest. Schuster underscored the potential for international investors to diversify into the region with attractive yields, signaling a promising outlook for REIT IPO activity.
The IPOX® Update 5/16/2025
Global IPO activity is buzzing, with significant movements across regions. In the U.S., tech firms like Figma are gearing up for major listings, while Omada Health has filed. The Asia-Pacific market, particularly Hong Kong, shows renewed vigor with CATL's $4.6 billion deal and substantial offerings from Jiangsu Hengrui and Foshan Haitian. Meanwhile, Dubai Residential REIT's offering in the MENA region saw strong demand, and Europe's Newlat Food is exploring a London IPO.
The IPOX® Update 5/9/2025
Global IPO markets show varied activity. In the U.S., travel tech firm Navan is preparing a significant IPO potentially valued over $8 billion, while eToro targets a $4 billion valuation. Asia-Pacific is bustling, highlighted by CATL's $5 billion Hong Kong listing and Chery Automobile's $1.5 billion plan. The MENA region, particularly Saudi Arabia with flynas and strong Q1 results, alongside a new Dubai REIT, displays robust momentum. Europe sees future plans from BASF's agriculture arm.
Bloomberg: IPOX® Founder Josef Schuster Discusses Improving IPO Market and Insurance Listings
In a recent Bloomberg article, IPOX® Founder Josef Schuster provided his expert commentary on the evolving landscape for IPOs. He highlighted a significant shift towards a more favorable market environment with reduced risk, expressing optimism for upcoming insurance sector listings like Aspen and American Integrity. Schuster noted these IPOs are poised to perform well, signaling a potential revival in investor appetite.